(Q34760603)

4 August 2017

1 reference

title

Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis (English)

1 reference

4 August 2017

1 reference

Raphael Duivenvoorden

3

object named as

Raphaël Duivenvoorden

1 reference

4 August 2017

Eric de Groot

1

1 reference

4 August 2017

Sander I van Leuven

2

1 reference

4 August 2017

Marijn C Meuwese

4

1 reference

4 August 2017

Fatima Akdim

5

1 reference

4 August 2017

Michiel L Bots

6

1 reference

4 August 2017

John Jp Kastelein

7

1 reference

4 August 2017

11 March 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

4 August 2017

1 reference

4 August 2017

5

1 reference

4 August 2017

5

1 reference

4 August 2017

280-288

1 reference

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study

4 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Noninvasive Tests of Atherosclerotic Burden : Writing Group III

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

Compensatory enlargement of human atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Arterial remodeling and coronary artery disease: the concept of "dilated" versus "obstructive" coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Coronary heart disease in the Framingham study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Mortality by cause for eight regions of the world: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Surrogate endpoints: a basis for a rational approach

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Surrogate endpoints in clinical trials: definition and operational criteria

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Mannheim intima-media thickness consensus.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Carotid Plaques Increase the Risk of Stroke and Subtypes of Cerebral Infarction in Asymptomatic Elderly

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

High-resolution B-Mode Ultrasound Scanning Methods in the Atherosclerosis Risk in Communities Study (ARIC)

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

[Intima media thickness of the carotid arteries: early pointer to arteriosclerosis and therapeutic endpoint]

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Surrogate endpoints in clinical trials: cardiovascular diseases.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effect of ACAT inhibition on the progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Measurement of arterial wall thickness as a surrogate marker for atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

The DICOM standard. A breakthrough for digital information exchange in cardiology

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Digital storage of echocardiograms offers superior image quality to analog storage, even with 20:1 digital compression: results of the Digital Echo Record Access Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Variance components analysis of carotid and femoral intima-media thickness measurements. REGRESS Study Group, Interuniversity Cardiology Institute of The Netherlands, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Ultrasound assessment of atherosclerotic vessel wall changes: reproducibility of intima-media thickness measurements in carotid and femoral arteries

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Atherosclerosis imaging as a benchmark in the development of novel cardiovasular drugs

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Carotid Intima-Media Thickness and Antihypertensive Treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Ant

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years of follow-up

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effect of torcetrapib on the progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1163

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO1163

1 reference

4 August 2017

1 reference